Pharmacokinetic analysis demonstrates favorable ADME properties of novel phenyltriazole-based sulfonamides against resistant pathogens, highlighting their therapeutic potential against MRSA biofilms.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hussien et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: